The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption-a nation-wide perspective in Sweden

Author： Askmark H.   Antonov K.   Aquilonius S.-M.  

Publisher： Elsevier

ISSN： 1353-8020

Source： Parkinsonism and Related Disorders, Vol.9, Iss.5, 2003-06, pp. : 271-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa

By Lev Nirit   Djaldetti Ruth   Melamed Eldad  

Journal of Neurology, Vol. 254, Iss. 5, 2007-09 ,pp. : 19-26

Springer Publishing Company

Access to resources Recommend Favorite

Acute psychological disorders in patients with epilepsy: a nation-wide study

By Cockerell O.C.   Moriarty J.   Trimble M.   Sander J.W.A.S.   Shorvon S.D.  

Epilepsy Research, Vol. 25, Iss. 2, 1996-10 ,pp. : 119-131

Elsevier

Access to resources Recommend Favorite

Conversion from dopamine agonists to pramipexole

By Linazasoro G.  

Journal of Neurology, Vol. 251, Iss. 3, 2004-03 ,pp. : 335-339

Springer Publishing Company

Access to resources Recommend Favorite

New Strategies with Dopaminergic Drugs: Modified Formulations of Levodopa and Novel Agonists

By Goetz C.G.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 17-20

Elsevier

Access to resources Recommend Favorite

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P.   Gerlach M.   Double K. L.   Riederer P.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite